NYSE:RMDMedical Equipment
A Look At ResMed (RMD) Valuation After Robust Q2 Beat And Upgraded Analyst Outlook
ResMed (RMD) is back in focus after a strong fiscal Q2, where its Masks & Accessories and Devices businesses outperformed expectations and analysts responded by lifting their financial outlook and maintaining positive coverage.
See our latest analysis for ResMed.
ResMed’s share price has moved to US$258.91, with a 6.15% 90 day share price return and a 1 year total shareholder return of 11.4%. This suggests momentum has been building around its recent Q2 beat and margin guidance.
If this Q2...